ACM
LGND icon

Argent Capital Management’s Ligand Pharmaceuticals LGND Stock Holding History

Argent Capital Management’s Portfolio LGND Stock Details LGND Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$1.11M Sell
3,539
-263
-7% -$77.7K 0.04% 122
2026
Q2 		$1.2M Buy
3,802
+317
+9% +$74.7K 0.04% 110
2026
Q1 		$696K Buy
+3,485
New +$690K 0.02% 131

Other funds holding LGND

CAM
Congress Asset Management Boston, Massachusetts $15.4B AUM 30.35% 1-Year Est. Return
MNBTD
Moody National Bank Trust Division Galveston, Texas $1.21B AUM 28.25% 1-Year Est. Return
VAG
VisionPoint Advisory Group Dallas, Texas $636M AUM 21.4% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return
CA
CoreCap Advisors Southfield, Michigan $3.48B AUM 21.43% 1-Year Est. Return
GWM
GK Wealth Management Reno, Nevada $178M AUM 41.48% 1-Year Est. Return
VCM
Versant Capital Management Phoenix, Arizona $1.17B AUM 28.44% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return
MPWT
MassMutual Private Wealth & Trust Windsor, Connecticut $3.79B AUM 19.33% 1-Year Est. Return
RWS
Retirement Wealth Solutions Marshfield, Wisconsin $189M AUM 13.41% 1-Year Est. Return

Argent Capital Management's LGND Position: Q3 2026 in Review

Argent Capital Management reduced its Ligand Pharmaceuticals (LGND) stake by 6.9% in Q3 2026, selling an estimated $77.7K and leaving 3,539 shares worth $1.11M. The position accounts for 0.04% of the portfolio, ranked #122.

Argent Capital Management first reported a position in LGND in Q1 2026 and has held it in 3 quarters since. The position peaked at $1.2M in Q2 2026. 14 funds tracked by Wall St. Rank hold LGND as of Q3 2026.

  • Argent Capital Management held 3,539 shares of Ligand Pharmaceuticals worth $1.11M as of Q3 2026.
  • Argent Capital Management sold 263 Ligand Pharmaceuticals shares in Q3 2026, an estimated $77.7K.
  • Ligand Pharmaceuticals made up 0.04% of Argent Capital Management's portfolio in Q3 2026, its #122 holding.
  • Argent Capital Management first reported a position in Ligand Pharmaceuticals in Q1 2026 and has held it in 3 quarters since.
  • Argent Capital Management's Ligand Pharmaceuticals position peaked at $1.2M in Q2 2026.
  • 14 funds tracked by Wall St. Rank held Ligand Pharmaceuticals as of Q3 2026.

Based on Argent Capital Management's 13F filing for Q3 2026, filed 5 Oct 2026.